Search
for
Sort by
Research 541–570 of 1000+
- Pathways to inflammation: acne pathophysiology
- Perspectives of Kennedy's disease
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Potential targets in the discovery of new hair growth promoters for androgenic alopecia
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Epitestosterone
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Dihydrotestosterone Stimulates 5a-Reductase Activity in Pubic Skin Fibroblasts*
- Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- Cellular actions of testosterone in vascular cells: Mechanism independent of aromatization to estradiol
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Molecular Genetic and Endocrine Mechanisms of Hair Growth
- Characteristics of Androgenetic Alopecia in Asian
- Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
- Clinical biochemistry of dihydrotestosterone
- Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: A possible androgenic bone protective effects induced by exemestane
- The genetics of androgenetic alopecia
- Red Ginseng Extract Promotes the Hair Growth in Cultured Human Hair Follicles
- Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Idiopathic Hirsutism*
- The extract of Thujae occidentalis semen inhibited 5α-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse
- Hormonal treatment of acne vulgaris: an update
- A Mouse Model of Androgenetic Alopecia
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Spinal and bulbar muscular atrophy: pathogenesis and clinical management
- Men with Kennedy disease have a reduced risk of androgenetic alopecia
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?